IGnomix is a leading company providing wide range of genomics and molecular genetics services in research and clinical setting across an array of markets for genomic medicine, biomarkers development and drug discovery. IGnomix utilizes research findings and scientific excellence to offer actionable report to guide physicians in avoiding unnessecery treatment causing serious side effects (multiple organ failure).

IGnomix is committed to improve the quality of life for patients through Genomic medicine and Molecular diagnostics
dna-test